VistaGen Therapeutics (VTGN)
0.24
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K Vistagen Therapeutics, For: Sep 10
September 11, 2026 6:02 AM - SEC Filing
Vistagen to Present at Psych Congress 2026
September 10, 2026 8:30 AM - StreetInsider
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: ORBIMED ADVISORS LLC
August 14, 2026 5:52 PM - SEC Filing
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: TCG Crossover GP I, LLC
August 14, 2026 4:32 PM - SEC Filing
Form 10-Q Vistagen Therapeutics, For: Jun 30
August 14, 2026 4:19 PM - SEC Filing
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: Commodore Capital LP
August 14, 2026 4:08 PM - SEC Filing
Form 8-K Vistagen Therapeutics, For: Aug 14
August 14, 2026 8:41 AM - SEC Filing
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
August 14, 2026 8:32 AM - Globe NewsWire
Form 8-K Vistagen Therapeutics, For: Aug 06
August 6, 2026 4:22 PM - SEC Filing
Vistagen reports Phase 2 repeat dose results for fasedienol in SAD
August 6, 2026 8:31 AM - StreetInsider
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
August 6, 2026 8:30 AM - StreetInsider
Form 8-K Vistagen Therapeutics, For: Aug 04
August 5, 2026 4:05 PM - SEC Filing
SRX Global acquires stake in Vistagen Therapeutics
August 4, 2026 5:00 AM - StreetInsider
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
August 4, 2026 5:00 AM - StreetInsider
Form DEFA14A Vistagen Therapeutics,
July 31, 2026 4:11 PM - SEC Filing
Form DEF 14A Vistagen Therapeutics, For: Jul 31
July 31, 2026 4:11 PM - SEC Filing
Form 4 Vistagen Therapeutics, For: Jul 29 Filed by: Williamson Douglas J
July 31, 2026 8:56 AM - SEC Filing
Form 3 Vistagen Therapeutics, For: Jul 29 Filed by: Williamson Douglas J
July 31, 2026 8:53 AM - SEC Filing
Form 8-K Vistagen Therapeutics, For: Jul 29
July 31, 2026 8:49 AM - SEC Filing
Vistagen names neuroscience veteran Douglas Williamson to its board
July 31, 2026 8:30 AM - StreetInsider
Vistagen Appoints Douglas J. Williamson to its Board of Directors
July 31, 2026 8:30 AM - StreetInsider
Form 4 Vistagen Therapeutics, For: Jun 30 Filed by: Adler Reid G.
July 2, 2026 4:34 PM - SEC Filing
Form 4 Vistagen Therapeutics, For: Jun 30 Filed by: Tressler Nick B.
July 2, 2026 4:18 PM - SEC Filing
Form 4 Vistagen Therapeutics, For: Jun 30 Filed by: Singh Shawn
July 2, 2026 4:17 PM - SEC Filing
Form 8-K Vistagen Therapeutics, For: Jun 30
June 30, 2026 8:29 AM - SEC Filing
Vistagen's fasedienol misses Phase 3 endpoints in anxiety trial
June 30, 2026 8:01 AM - StreetInsider
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
June 30, 2026 8:00 AM - BizWire
VistaGen Therapeutics (VTGN) Halted, News Pending
June 30, 2026 7:58 AM - StreetInsider
Full Article List
